Articles From: Arrow Electronics Reports First-Quarter Results to Arsenal Energy Releases Q1 Results and Announces Dividend Plans


2013/5/1
Arrow Electronics, Inc. (NYSE:ARW) today reported first-quarter 2013 net income of $77.9 million, or $.72 per share on a diluted basis, compared with net income of $113.6 million, or $1.00 per share on a diluted basis in the first quarter of 2012.
Sign-up for Arrow Electronics Reports First-Quarter Results investment picks
2013/2/7
Arrow Electronics, Inc. (NYSE:ARW) today reported fourth-quarter 2012 net income of $174.7 million, or $1.62 per share on a diluted basis, compared with net income of $174.1 million, or $1.53 per share on a diluted basis in the fourth quarter of 2011.
Sign-up for Arrow Electronics Reports Fourth-Quarter Non-GAAP Earnings Per Share of $1.22 investment picks
2013/3/20
Arrow Electronics, Inc. (NYSE: ARW) has signed a distribution agreement with Critical Link, a leader in the development of embedded systems with expertise in a broad range of electronic applications.
Sign-up for Arrow Electronics Signs Global Distribution Agreement with Critical Link investment picks
2013/4/17
Arrow Electronics, Inc. (NYSE:ARW) announced that the company will host a conference call to discuss first-quarter financial results on May 1, 2013, at 1:00 PM ET.
Sign-up for Arrow Electronics to Host First-Quarter 2013 Earnings Conference Call investment picks
2013/4/5
Arrow Electronics Inc. (NYSE:ARW) today announced that it will launch a corporate advertising campaign during the NCAA Division I men’s basketball Final Four games on April 6 and April 8.
Sign-up for Arrow Electronics to Launch First Ad Campaign During NCAA Final Four investment picks
2013/2/8
Arrow Electronics, Inc. (NYSE:ARW) announced that Paul J.
Sign-up for Arrow Electronics to Present at Upcoming Investor Conferences investment picks
2013/4/25
Arrow Electronics, Inc. (NYSE:ARW) announced that Andrew S.
Sign-up for Arrow Electronics to Present at Upcoming Investor Conferences investment picks
2013/3/20
Arrow Electronics Inc. (NYSE: ARW) announced the opening of a new facility in Sao Paulo, Brazil, that establishes a presence for the company’s value recovery (electronic and IT asset disposition) and reverse logistics businesses.
Sign-up for Arrow Establishes IT Asset Disposition and Reverse Logistics Presence and Expands Computer System Integration Operations in Brazil investment picks
2013/1/30
GLENS FALLS, N.Y. , Jan.
Sign-up for Arrow Financial Corporation Declares Cash Dividend investment picks
2013/5/1
GLENS FALLS, N.Y. , May 1, 2013 /PRNewswire/ -- The Board of Directors of Arrow Financial Corporation (NasdaqGS® – AROW) on May 1, 2013 , declared a quarterly cash dividend of $.25 per share payable June 14, 2013 , to shareholders of record June 3, 2013 .
Sign-up for Arrow Financial Corporation Declares Cash Dividend investment picks
2013/4/18
Arrow Electronics Inc. (NYSE: ARW) announced an agreement with Lenovo designating Arrow as its “partner of choice” for a new asset retirement service offered at the point of sale.
Sign-up for Arrow Named Asset Retirement Provider for Lenovo in North America investment picks
2013/4/19
GLENS FALLS, N.Y. , April 19, 2013 /PRNewswire/ -- Arrow Financial Corporation (NasdaqGS® – AROW) announced operating results for the three-month period ended March 31, 2013.
Sign-up for Arrow Reports Solid First Quarter Results and Strong Asset Quality investment picks
2013/4/8
Celebrating the impact that innovation has on improving daily life, Arrow Electronics Inc. (NYSE:ARW) today announced a multifaceted, multichannel awareness effort designed to promote the company’s leading position in the electronics supply chain and distribution industry and its communities.
Sign-up for Arrow’s Brand Campaign Highlights Innovation’s Role as Key Economic Driver investment picks
2013/5/6
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that on May 3, 2013 it closed a previously announced private offering of common and convertible preferred stock with gross proceeds of $36 million.
Sign-up for Arrowhead Closes $36 Million Private Offering investment picks
2013/2/26
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced the publication of data demonstrating multi-log reductions in hepatitis B viral DNA and proteins lasting over 30 days after a single injection in animal models.
Sign-up for Arrowhead Data Demonstrates RNAi Candidate ARC-520 Silences Hepatitis B Virus investment picks
2013/3/25
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, will host an analyst event today in New York City to discuss ARC-520, its RNAi-based candidate designed to treat chronic hepatitis B virus infection.
Sign-up for Arrowhead Induces 90% Reduction in Hepatitis B Antigens in Chimpanzee with Chronic Infection: Data Follow Previous Report of Reduction in Viral DNA investment picks
2013/4/29
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it has priced a private offering with gross proceeds expected to be $36 million.
Sign-up for Arrowhead Prices $36 Million Private Offering investment picks
2013/2/28
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Number 13/336,028 entitled, “In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages.” This new IP expands the Dynamic Polyconjugate (DPC) platform, broadly protecting Arrowhead's next generation DPC polymer masking technology.
Sign-up for Arrowhead Receives Notice of Patent Allowance for New Protease Sensitive Masking Chemistry for DPC siRNA Delivery System investment picks
2013/5/7
Arrowhead Research Corporation (NASDAQ:ARWR) , a targeted therapeutics company, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Number 13/326,433 entitled, “Peptide-Based In Vivo siRNA Delivery System.” The allowed claims specifically protect the use of targeted melittin or melittin-like peptides to facilitate delivery of siRNA conjugates to hepatocytes.
Sign-up for Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone investment picks
2013/2/13
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced financial results for its fiscal 2013 first quarter ended December 31, 2012.
Sign-up for Arrowhead Reports Fiscal 2013 First Quarter Financial Results investment picks
2013/5/9
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced financial results for its fiscal 2013 second quarter ended March 31, 2013.
Sign-up for Arrowhead Reports Fiscal 2013 Second Quarter Financial Results investment picks
2013/3/14
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that a study of its RNAi-based candidate ARC-520 in a chimpanzee chronically infected with the human hepatitis B virus (HBV) supports findings from rodent models indicating that it can knock down HBV DNA and key viral antigens.
Sign-up for Arrowhead RNAi Candidate ARC-520 Induces Greater than 90% Reduction in Circulating HBV DNA in Chimpanzee with Chronic Hepatitis B investment picks
2013/3/7
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it will host an analyst and investor event on Monday, March 25, from 12:30 to 2:00 p.m. EST in New York City.
Sign-up for Arrowhead to Host Analyst Event in New York to Discuss RNAi-based Hepatitis B Candidate ARC-520 investment picks
2013/4/24
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that its President and CEO, Dr.
Sign-up for Arrowhead to Present at Master Investor 2013 investment picks
2013/4/24
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that its COO and Head of R&D, Dr.
Sign-up for Arrowhead to Present at Needham Healthcare Conference investment picks
2013/2/1
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that academic collaborators and scientists from the company will present data on the Dynamic PolyConjugate™ (DPC) siRNA delivery system, the ARC-520 hepatitis B drug candidate, and the Homing Peptide™ platform at upcoming scientific conferences.
Sign-up for Arrowhead to Present at Upcoming Scientific Conferences investment picks
2013/2/6
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced that it will report its financial results for the fiscal 2013 first quarter ended December 31, 2012, on Wednesday, February 13, 2013 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate in the conference call, please dial 877-317-6789 (toll free from the US), 866-605-3852 (toll free from Canada), or 412-317-6789 (for international callers). Investors may also access a live audio webcast of this conference call on the Company's website at www.arrowheadresearch.com .
Sign-up for Arrowhead to Report Fiscal 2013 First Quarter Financial Results investment picks
2013/5/2
Arrowhead Research Corporation (NASDAQ:ARWR) , a targeted therapeutics company, today announced that it will report its financial results for the fiscal 2013 second quarter ended March 31, 2013, on Thursday, May 9, 2013, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate in the conference call, please dial 877-317-6789 (toll free from the US), 866-605-3852 (toll free from Canada), or 412-317-6789 (for international callers). Investors may also access a live audio webcast of this conference call on the Company's website at www.arrowheadresearch.com .
Sign-up for Arrowhead to Report Fiscal 2013 Second Quarter Financial Results investment picks
2013/3/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0861065001&sourceType=1 http://www.ccnmatthews.com/logos/20050930-arsenal.jpg CALGARY, ALBERTA --
Sign-up for Arsenal Energy Inc. Announces 2012 Fourth Quarter and Year End Results investment picks
2013/5/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0871729001&sourceType=1 http://www.ccnmatthews.com/logos/20050930-arsenal.jpg CALGARY, ALBERTA --
Sign-up for Arsenal Energy Releases Q1 Results and Announces Dividend Plans investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Arrow Electronics Reports First-Quarter Results to Arsenal Energy Releases Q1 Results and Announces Dividend Plans
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity